Recent advances in neuroendocrine imaging

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 15, Issue 4, 2008, Pages 371-375

  Keogh, Bart P ^a  

^a SWEDISH MEDICAL CENTER   (United States)

Author keywords

MRI; Neuroendocrine; Perfusion; Pituitary

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID NOC GA 68; ALCOHOL; CORTICOTROPIN; DOPAMINE RECEPTOR BLOCKING AGENT; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; HYPOPHYSIS HORMONE; OCTREOTIDE; THYROTROPIN; TRACER; UNCLASSIFIED DRUG;

ADENOMA; ADRENAL CORTEX ADENOMA; ADRENAL GLAND; ANISOTROPY; ANTIANGIOGENIC ACTIVITY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CRANIOPHARYNGIOMA; CUSHING DISEASE; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FUNCTIONAL ANATOMY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAVES DISEASE; GROWTH HORMONE SECRETING ADENOMA; HEMODYNAMICS; HUMAN; HYPERCORTISOLISM; HYPERTHYROIDISM; HYPOPHYSIS; HYPOPHYSIS FUNCTION; HYPOPHYSIS TUMOR; INCIDENCE; LASER SURGERY; LYMPHOMA; METASTASIS; NEUROENDOCRINE DISEASE; NEUROENDOCRINE SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARATHYROID TUMOR; PARENCHYMA; PATHOLOGICAL ANATOMY; PERFUSION WEIGHTED IMAGING; POSITRON EMISSION TOMOGRAPHY; PROLACTINOMA; REVIEW; SENSITIVITY AND SPECIFICITY; TERATOMA; THYROID ADENOMA; THYROID CANCER; THYROID CARCINOMA; THYROID GLAND; THYROID TUMOR; THYROTROPIN SECRETING ADENOMA; BRAIN; BRAIN TUMOR; ENDOCRINE DISEASE; PARATHYROID GLAND; PATHOLOGY;

ADRENAL GLANDS; BRAIN; BRAIN NEOPLASMS; ENDOCRINE SYSTEM DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; PARATHYROID GLANDS; PITUITARY GLAND; THYROID GLAND;

EID: 55249112966     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e328305085b     Document Type: Review

References (43)

1. George JT, Thow JC, Matthews B, et al. Atrial fibrillation associated with a thyroid stimulating hormone-secreting adenoma of the pituitary gland leading to a presentation of acute cardiac decompensation: a case report. J Med Case Reports 2008; 28:67.
2. Foppiani L, Del Monte P, Ruelle A, et al. TSH-secreting adenomas: rare pituitary tumors with multifaceted clinical and biological features. J Endocrinol Invest 2007; 30:603-609.
3. Sahdev A, Reznek RH, Evanson J, Grossman AB. Imaging in Cushing's syndrome. Arq Bras Endocrinol Metabol 2007; 51:1319-1328.
4. Batista DL, Riar J, Keil M, Stratakis CA. Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics 2007; 120:e575-e586.
5. Vieira JO Jr, Cukiert A, Liberman B. Evaluation of magnetic resonance imaging criteria for cavernous sinus invasion in patients with pituitary adenomas: logistic regression analysis and correlation with surgical findings. Surg Neurol 2006; 65:130-135.
6. Yoneoka Y, Watanabe N, Matsuzawa H, et al. Preoperative depiction of cavernous sinus invasion by pituitary macroadenoma using three-dimensional anisotropy contrast periodically rotated overlapping parallel lines with enhanced reconstruction imaging on a 3-tesla system. J Neurosurg 2008; 108:37-41. The use of anisotropy-based imaging in the evaluation of fiber tracks will probably continue to grow, using this kind of imaging approach.
7. Friedman TC, Zuckerbraun E, Lee ML, et al. Dynamic pituitary MRI has high sensitivity and specificity for the diagnosis of mild Cushing's syndrome and should be part of the initial workup. Horm Metab Res 2007; 39:451-456.
8. Kim LJ, Lekovic GP, White WL, Karis J. Preliminary experience with 3-Tesla MRI and Cushing's disease. Skull Base 2007; 17:273-277.
9. Pinker K, Ba-Ssalamah A, Wolfsberger S, et al. The value of high-field MRI (3T) in the assessment of sellar lesions. Eur J Radiol 2005; 54:327-334.
10. Gazioglu N, Ulu MO, Ozlen F, et al. Management of Cushing's disease using cavernous sinus sampling: effectiveness in tumor lateralization. Clin Neurol Neurosurg 2008; 110:333-338.
11. Gandhi CD, Meyer SA, Patel AB, et al. Neurologic complications of inferior petrosal sinus sampling. AJNR Am J Neuroradiol 2008; 29:760-765. IPSS continues to be important in a subset of patients in which imaging fails to provide adequate localization information.
12. Jagannathan J, Sheehan JP, Pouratian N, et al. Gamma knife surgery for Cushing's disease. J Neurosurg 2007; 106:980-987. Noninvasive approaches to pituitary disease are currently limited, but likely to expand with improvements in radiotherapy.
13. Davis SM, Donnan GA, Parsons MW, et al., for the EPITHET investigators. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol 2008; 7:299-309.
14. Manuchehri AM, Sathyapalan T, Lowry M, et al. Effect of dopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging. Pituitary 2007; 10:261-266. These authors use perfusion-imaging techniques to address a fundamental biological question in the method of action of pharmacotherapeutics in pituitary tumors. This study and similar imaging approaches will probably form part of the basis for more individualized therapy.
15. Sathyapalan T, Lowry M, Turnbull LW, et al. Mechanism of action of octreotide in acromegalic tumours in vivo using dynamic contrast-enhanced magnetic resonance imaging. Pituitary 2007; 10:233-236.
16. Schneider HJ, Aimaretti G, Kreitschmann-Andermahr I, et al. Hypopituitarism. Lancet 2007; 369:1461-1470.
17. Vieira TC, Boldarine VT, Abucham J. Molecular analysis of PROP1, PIT1, HESX1, LHX3, and LHX4 shows high frequency of PROP1 mutations in patients with familial forms of combined pituitary hormone deficiency. Arq Bras Endocrinol Metabol 2007; 51:1097-1103.
18. do Amaral LL, Ferreira RM, Ferreira NP, et al. Combined pituitary hormone deficiency and PROP-1 mutation in two siblings: a distinct MR imaging pattern of pituitary enlargement. AJNR Am J Neuroradiol 2007; 28:1369-1370.
19. Sherafat-Kazemzadeh R, Mehta SN, Care MM, et al. Fanconi Anemia Comprehensive Care Center. Small pituitary size in children with Fanconi anemia. Pediatr Blood Cancer 2007; 49:166-170.
20. Garel C, Léger J. Contribution of magnetic resonance imaging in nontumoral hypopituitarism in children. Horm Res 2007; 67:194-202.
21. Maiya B, Newcombe V, Nortje J, et al. Magnetic resonance imaging changes in the pituitary gland following acute traumatic brain injury. Intensive CareMed 2008; 34:468-475.
22. Isidori AM, Lenzi A. Ectopic ACTH syndrome. Arq Bras Endocrinol Metabol 2007; 51:1217-1225.
23. Isidori AM, Kaltsas GA, Pozza C, et al. The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term followup. J Clin Endocrinol Metab 2006; 91:371-377.
24. Kumar J, Spring M, Carroll PV, et al. 18Flurodeoxyglucose positron emission tomography in the localization of ectopic ACTH-secreting neuroendocrine tumours. Clin Endocrinol (Oxf) 2006; 64:371-374.
25. Mishra AK, Agarwal A, Gupta S, et al. Outcome of adrenalectomy for Cushing's syndrome: experience from a tertiary care center. World J Surg 2007; 31:1425-1432.
26. Schirpenbach C, Reincke M. Primary aldosteronism: current knowledge and controversies in Conn's syndrome. Nat Clin Pract Endocrinol Metab 2007; 3:220-227.
27. Merkle EM, Schindera ST. MR imaging of the adrenal glands: 1.5T versus 3T. Magn Reson Imaging Clin N Am 2007; 15:365-372.
28. Inan N, Arslan A, Akansel G, et al. Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses. Eur J Radiol 2008; 65:154-162.
29. National Cancer Institute. SEER cancer statistics review. Bethesda, MD: National Cancer Institute; 1975-2004.
30. Tarantino L, Francica G, Sordelli I, et al. Percutaneous ethanol injection of hyperfunctioning thyroid nodules: long-term follow-up in 125 patients. AJR Am J Roentgenol 2008; 190:800-808.
31. Døssing H, Bennedbaek FN, Bonnema SJ, et al. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol 2007; 157:95-100.
32. Leboulleux S, Schroeder PR, Schlumberger M, Ladenson PW. The role of PET in follow-up of patients treated for differentiated epithelial thyroid cancers. Nat Clin Pract Endocrinol Metab 2007; 3:112-121; Review.
33. Fletcher JW, Djulbegovic B, Soares HP, et al. Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 2008; 49:480-508.
34. Giraudet AL, Vanel D, Leboulleux S, et al. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels. J Clin Endocrinol Metab 2007; 92:4185-4190.
35. Fanti S, Ambrosini V, Tomassetti P, et al. Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET. Biomed Pharmacother 2008 [Epub ahead of print].
36. Müssig K, Schraml C, Gallwitz B, et al. A novel MR-imaging technique using arterial spin labeling for thyroid gland perfusion in thyrotoxicosis. Thyroid 2007; 17:1155-1156.
37. Schraml C, Boss A, Martirosian P, et al. FAIR true-FISP perfusion imaging of the thyroid gland. J Magn Reson Imaging 2007; 26:66-71. MRI-based physiological imaging using perfusion-based sequences might have significant impact on understanding thyroid gland disorder. This study is the first description of fundamental magnetic-resonance perfusion parameters in the normal thyroid gland.
38. Zhu DF, Wang ZX, Zhang DR, et al. fMRI revealed neural substrate for reversible working memory dysfunction in subclinical hypothyroidism. Brain 2006; 129:2923-2930.
39. Bonucchi J, Hassan I, Policeni B, Kaboli P. Thyrotoxicosis associated Wernicke's encephalopathy. J Gen Intern Med 2008; 23:106-109.
40. Rubello D, Gross MD, Mariani G, Al-Nahhas A. Scintigraphic techniques in primary hyperparathyroidism: from preoperative localization to intra-operative imaging. Eur J Nucl Med Mol Imaging 2007; 34:926-933.
41. Whitson BA, Broadie TA. Preoperative ultrasound and nuclear medicine studies improve the accuracy in localization of adenoma in hyperparathyroidism. Surg Today 2008; 38:222-226.
42. Sukan A, Reyhan M, Aydin M, et al. Preoperative evaluation of hyperparathyroidism: the role of dual-phase parathyroid scintigraphy and ultrasound imaging. Ann Nucl Med 2008; 22:123-131.
43. Hessman O, Stålberg P, Sundin A, et al. High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 2008; 32:774-781.